Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
University of Arizona College of Medicine, Tucson.
A F
AF
List
T D
TD
Kummet
J D
JD
Adams
H G
HG
Chun
D058186:Acute Kidney Injury / Q000209:etiology; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D001088:Arabinonucleotides / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008207:Lymphatic Metastasis; D008297:Male; D015275:Tumor Lysis Syndrome / Q000097:blood / Q000209:etiology*; D001084:Vidarabine Phosphate / Q000009:adverse effects* / Q000031:analogs & derivatives
D000964:Antimetabolites, Antineoplastic; D001088:Arabinonucleotides; D001084:Vidarabine Phosphate; C042382:fludarabine phosphate